BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38879434)

  • 1. Usefulness of pancreatic volume quantitative analysis as a predictor of development and severity in post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Akazawa Y; Ohtani M; Nosaka T; Takahashi K; Naito T; Matsuda H; Nakamoto Y
    Pancreatology; 2024 Jun; ():. PubMed ID: 38879434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive correlation between pancreatic volume and post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Maruyama H; Shiba M; Ishikawa-Kakiya Y; Kato K; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Yamagami H; Tanigawa T; Watanabe T; Yamamoto A; Kabata D; Shintani A; Fujiwara Y
    J Gastroenterol Hepatol; 2020 May; 35(5):769-776. PubMed ID: 31618801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Park CH; Park SW; Yang MJ; Moon SH; Park DH
    Surg Endosc; 2022 Mar; 36(3):2052-2061. PubMed ID: 34231067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.
    Lee YK; Yang MJ; Kim SS; Noh CK; Cho HJ; Lim SG; Hwang JC; Yoo BM; Kim JH
    J Korean Med Sci; 2017 Nov; 32(11):1814-1819. PubMed ID: 28960034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for post-endoscopic retrograde cholangiopancreatography (ERCP) abdominal pain in patients without post-ERCP pancreatitis.
    Chen MJ; Zheng RH; Cao J; Yao YL; Wang L; Zou XP
    Hepatobiliary Pancreat Dis Int; 2022 Jun; 21(3):285-292. PubMed ID: 34924299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nafamostat Mesylate is Not Effective in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Matsumoto T; Okuwaki K; Imaizumi H; Kida M; Iwai T; Yamauchi H; Kaneko T; Hasegawa R; Masutani H; Tadehara M; Adachi K; Watanabe M; Kurosu T; Tamaki A; Kikuchi H; Ohno T; Koizumi W
    Dig Dis Sci; 2021 Dec; 66(12):4475-4484. PubMed ID: 33495919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pancreatic fat on the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Park CH; Chung MJ; Park DH; Min S; Park SW
    Surg Endosc; 2022 Aug; 36(8):5734-5742. PubMed ID: 35099627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Neutrophil-Lymphocyte Ratio as an Early Predictive Marker of the Severity of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Lee SH; Lee TY; Cheon YK
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056321
    [No Abstract]   [Full Text] [Related]  

  • 11. Post-endoscopic retrograde cholangiopancreatography pancreatitis assessed using criteria for acute pancreatitis.
    Suzuki A; Uno K; Nakase K; Mandai K; Endoh B; Chikugo K; Kawakami T; Suzuki T; Nakai Y; Kusumoto K; Itokawa Y; Inatomi O; Bamba S; Mizumoto Y; Tanaka K
    JGH Open; 2021 Dec; 5(12):1391-1397. PubMed ID: 34950783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged cannulation time is an independent risk factor for moderate-to-severe post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis: a large cohort study.
    Lou L; Wang X; Zhang Y; Luo H; Ren G; Zhang L; Liang S; Kang X; Shi X; Chen L; Lv Y; Wang X; Pan Y
    Ann Transl Med; 2023 Mar; 11(5):188. PubMed ID: 37007573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of endoscopic retrograde cholangiopancreatography in children].
    Yu ZP; Zhu L; Yang XP; Cao RL; Chen YX
    Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1295-1301. PubMed ID: 36444433
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors of post- endoscopic retrograde cholangiopancreatography pancreatitis in biliary type sphincter of Oddi dysfunction in Japanese patients.
    Miyatani H; Matsumoto S; Mashima H
    J Dig Dis; 2017 Oct; 18(10):591-597. PubMed ID: 28898571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of wire placement in the pancreatic duct and metal biliary stent as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Shin SH; So H; Cho S; Kim N; Baik GH; Lee SK; Park DH
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1201-1207. PubMed ID: 31830336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation.
    Thiruvengadam NR; Forde KA; Chandrasekhara V; Ahmad NA; Ginsberg GG; Khungar V; Kochman ML
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1224-1232.e1. PubMed ID: 31622734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and preventive measures for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Fujita K; Yazumi S; Matsumoto H; Asada M; Nebiki H; Matsumoto K; Maruo T; Takenaka M; Tomoda T; Onoyama T; Kurita A; Ueki T; Katayama T; Kawamura T; Kawamoto H;
    Dig Endosc; 2022 Sep; 34(6):1198-1204. PubMed ID: 34963021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of risk factors and prevention strategies of post-ERCP pancreatitis.
    Lin Y; Liu X; Cao DQ; Tang JH; Wen JJ; Li TF; Liu PF; Xia TS
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5185-5190. PubMed ID: 29228432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Post Endoscopic Retrograde Cholangiopancreatography Acute Pancreatitis in an Academic Hospital of Bangladesh.
    Islam MS; Khalil MM; Hossain MI; Datta RK; Podder S; Khan ST; Ahmed F; Ahmed F; Rahman MM; Kibria MG
    Mymensingh Med J; 2024 Jan; 33(1):133-139. PubMed ID: 38163784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.